TrialCancer research and treatment2020

Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies.

Myung-Ju Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.